ArabFinance: Arab Drug Company (ADCI) recorded a net profit after tax of EGP 49.46 million during the six-month period ended December 31st 2021, down from EGP 58.31 million in the same period of 2020, according to the company’s financial statement filed to the Egyptian Exchange (EGX).
Moreover, the company generated a net sale of EGP 280.57 million in the July-December period of 2021, compared to EGP 291.21 million in the same period of 2020.
Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.